Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Eyevensys
Eyevensys
Activities:
Manufacturing
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Eyevensys appoints Violaine Desort-Henin as Clinical Director
To oversee the development of the clinical develop0ment programme at the company
Research & Development
Francesco Sinigaglia becomes Chairman at Eyevensys
Raffy Kazandjian is Chief Executive at the French ophthalmic company
Research & Development
Eyevensys hires Dr Ivan Cohen-Tanugi as CEO
First plans to conclude preclinical tests of new non-viral gene therapy process
Subscribe now